Unlike traditional pain management, ReActiv8 therapy uniquely addresses chronic low back pain by restoring neuromuscular control and functional spine stability.
In this episode, Dr. Chris Gilligan, MD, MBA, Executive Medical Director, Mass General Brigham Global Advisory, Senior Medical Director of Periprocedural Services, Director of Brigham and Women’s Spine Service Line, Chief - Division of Pain Medicine, Brigham and Women’s Hospital, discusses the groundbreaking five-year data on ReActiv8 therapy for chronic low back pain, offering insights into this transformative approach and its impact on patients' lives. Chris delves into the significant findings from his research, shedding light on the ReActiv8 therapy's effectiveness in addressing chronic low back pain and improving patients' quality of life. He provides an in-depth overview of the research, covering the methodology, patient demographics, and the remarkable outcomes achieved over the five-year study period. Dr. Gilligan also addresses the implications of the findings for payers, providers, and patients, offering a holistic perspective on the therapy's clinical and economic significance.
Join Chris and Saul as they uncover the remarkable impact of this novel therapy and explore its broader implications for patients, physicians, and payers in the healthcare ecosystem.
Resources:
View all episodes
By Saul Marquez
4.9
111111 ratings
Unlike traditional pain management, ReActiv8 therapy uniquely addresses chronic low back pain by restoring neuromuscular control and functional spine stability.
In this episode, Dr. Chris Gilligan, MD, MBA, Executive Medical Director, Mass General Brigham Global Advisory, Senior Medical Director of Periprocedural Services, Director of Brigham and Women’s Spine Service Line, Chief - Division of Pain Medicine, Brigham and Women’s Hospital, discusses the groundbreaking five-year data on ReActiv8 therapy for chronic low back pain, offering insights into this transformative approach and its impact on patients' lives. Chris delves into the significant findings from his research, shedding light on the ReActiv8 therapy's effectiveness in addressing chronic low back pain and improving patients' quality of life. He provides an in-depth overview of the research, covering the methodology, patient demographics, and the remarkable outcomes achieved over the five-year study period. Dr. Gilligan also addresses the implications of the findings for payers, providers, and patients, offering a holistic perspective on the therapy's clinical and economic significance.
Join Chris and Saul as they uncover the remarkable impact of this novel therapy and explore its broader implications for patients, physicians, and payers in the healthcare ecosystem.
Resources:
4,333 Listeners
30,652 Listeners
1,466 Listeners
2,665 Listeners
25,785 Listeners
12,642 Listeners
30,243 Listeners
110,635 Listeners
55,921 Listeners
478 Listeners
9,507 Listeners
182 Listeners
12,954 Listeners
15,395 Listeners
10,667 Listeners